Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fully Resorbable Sinus Drug-eluting Stents in ECRSwNP After Surgery
NCT07498374Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in chronic rhinosinusitis with nasal polyps (CRSwNP) (4 arms), sponsored by Tangdu Hospital. Primary endpoints: Median Time to Early Polyp/Edema Recurrence at 6 months, Incidence Rate of Early Polyp/Edema Recurrence at 6 months and 1 more. Started Jan 2026; status: recruiting.
02
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07498374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07498374.